Use for cannabinoid

Roger Guy Pertwee (Inventor), Geoffrey W Guy (Inventor)

Research output: Patent

1 Citation (Scopus)

Abstract

The invention relates to the use of one or more cannabinolds in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from neutral antagonism of the CB, cannabinoid receptor. Preferably the cannabinoid is tetrahydrocannabivarin (THCV). Preferably the diseases and conditions to be treated are taken from the group: obesity, schizophrenia, epilepsy, cognitive disorders such as Alzheimer's, bone disorders, bulimia, obesity associated with type n diabetes (non-insulin dependant diabetes) and in the treatment of drug, alcohol and nicotine abuse or dependency.
Original languageEnglish
Patent numberUS2008119544
IPCA61K31/353; A61K36/185; A61K31/352;
Publication statusPublished - 22 May 2008

Fingerprint

Cannabinoids
Obesity
Cannabinoid Receptors
Bulimia
Nicotine
Alcoholism
Epilepsy
Schizophrenia
Bone and Bones
Pharmaceutical Preparations
Dependency (Psychology)

Cite this

Pertwee, R. G., & Guy, G. W. (2008). IPC No. A61K31/353; A61K36/185; A61K31/352; . Use for cannabinoid. (Patent No. US2008119544).

Use for cannabinoid. / Pertwee, Roger Guy (Inventor); Guy, Geoffrey W (Inventor).

IPC No.: A61K31/353; A61K36/185; A61K31/352; . Patent No.: US2008119544.

Research output: Patent

Pertwee, RG & Guy, GW 2008, Use for cannabinoid, Patent No. US2008119544, IPC No. A61K31/353; A61K36/185; A61K31/352; .
Pertwee RG, Guy GW, inventors. Use for cannabinoid. A61K31/353; A61K36/185; A61K31/352; . 2008 May 22.
Pertwee, Roger Guy (Inventor) ; Guy, Geoffrey W (Inventor). / Use for cannabinoid. IPC No.: A61K31/353; A61K36/185; A61K31/352; . Patent No.: US2008119544.
@misc{870f2dfe95114ab9859ccba42518838d,
title = "Use for cannabinoid",
abstract = "The invention relates to the use of one or more cannabinolds in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from neutral antagonism of the CB, cannabinoid receptor. Preferably the cannabinoid is tetrahydrocannabivarin (THCV). Preferably the diseases and conditions to be treated are taken from the group: obesity, schizophrenia, epilepsy, cognitive disorders such as Alzheimer's, bone disorders, bulimia, obesity associated with type n diabetes (non-insulin dependant diabetes) and in the treatment of drug, alcohol and nicotine abuse or dependency.",
author = "Pertwee, {Roger Guy} and Guy, {Geoffrey W}",
year = "2008",
month = "5",
day = "22",
language = "English",
type = "Patent",
note = "US2008119544; A61K31/353; A61K36/185; A61K31/352;",

}

TY - PAT

T1 - Use for cannabinoid

AU - Pertwee, Roger Guy

AU - Guy, Geoffrey W

PY - 2008/5/22

Y1 - 2008/5/22

N2 - The invention relates to the use of one or more cannabinolds in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from neutral antagonism of the CB, cannabinoid receptor. Preferably the cannabinoid is tetrahydrocannabivarin (THCV). Preferably the diseases and conditions to be treated are taken from the group: obesity, schizophrenia, epilepsy, cognitive disorders such as Alzheimer's, bone disorders, bulimia, obesity associated with type n diabetes (non-insulin dependant diabetes) and in the treatment of drug, alcohol and nicotine abuse or dependency.

AB - The invention relates to the use of one or more cannabinolds in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from neutral antagonism of the CB, cannabinoid receptor. Preferably the cannabinoid is tetrahydrocannabivarin (THCV). Preferably the diseases and conditions to be treated are taken from the group: obesity, schizophrenia, epilepsy, cognitive disorders such as Alzheimer's, bone disorders, bulimia, obesity associated with type n diabetes (non-insulin dependant diabetes) and in the treatment of drug, alcohol and nicotine abuse or dependency.

M3 - Patent

M1 - US2008119544

ER -